Brian Michael Bonnell sold $1.6M of ICUI
Chief Financial Officer at ICU MEDICAL INC/DE. 9,307 shares at an average of $172.79, traded Aug 31, 2026, filed Aug 31, 2026.
Score components
- +22RoleCFO
- +25Trade size$1.6M at market
- +5Share of holdings soldSold 13% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001804831-26-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | SOpen-market sale Common Stock10b5-1 | -1,712 | $171.05 | $293k | 70,038 | 44 d ago |
| Aug 31, 2026 | SOpen-market sale Common Stock10b5-1 | -1,914 | $172.12 | $329k | 68,124 | 44 d ago |
| Aug 31, 2026 | SOpen-market sale Common Stock10b5-1 | -4,568 | $173.44 | $792k | 63,556 | 44 d ago |
| Aug 31, 2026 | SOpen-market sale Common Stock10b5-1 | -1,113 | $173.91 | $194k | 62,443 | 44 d ago |
Related signals
Other insiders at ICU MEDICAL INC/DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | ICU MEDICAL INC/DE | Virginia Ruth Sanzone VP, General Counsel | $819k 4,856 shares | -25% | |
| 40Moderate | ICU MEDICAL INC/DE | Brian Michael Bonnell Chief Financial Officer | $1.1M 6,381 shares | -10% | |
| 60Notable | ICU MEDICAL INC/DE | Daniel Woolson VP, GM-Infusion Capital | $982k 5,417 shares | -24% | |
| 56Moderate | ICU MEDICAL INC/DE | Ben Sousa Chief Information Officer | $401k 2,250 shares | -42% | |
| 38Weak | ICU MEDICAL INC/DE | Elisha W Finney director | $69k 378 shares | -7% | |
| 65Notable | ICU MEDICAL INC/DE | Christian B. Voigtlander Chief Operating Officer | $1.6M 8,929 shares | -19% | |
| 49Moderate | ICU MEDICAL INC/DE | Daniel Woolson President | $281k 2,123 shares | -9% | |
| 49Moderate | ICU MEDICAL INC/DE | Virginia Ruth Sanzone VP, General Counsel | $304k 2,447 shares | -11% | |
| 34Weak | ICU MEDICAL INC/DE | David C. Greenberg director | $298k 2,424 shares | -23% | |
| 52Moderate | ICU MEDICAL INC/DE | Daniel Woolson VP, GM-Infusion Capital | $441k 2,897 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.